Honglei Chen

11PUBLICATIONS
25CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 27, 2026
Adenocarcinoma admixed with neuroendocrine carcinoma of the cervix: a clinicopathological diagnostic study and molecular features.

Miao Yu, Min Jiang, Xinrong Zhang

|Nov 14, 2024
Expression of SIGLEC15 correlates with tumor immune infiltration, molecular subtypes, and breast cancer progression.

Huan Lai, Yiyang Liu, Yan Gong

|Jan 18, 2023
Tumor immune microenvironment components and the other markers can predict the efficacy of neoadjuvant chemotherapy for breast cancer.

Weiqian Zhang, Ke Xu, Zhengfa Li

|Dec 11, 2022
GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis.

Yue Xi, Tiange Zhang, Wei Sun

|Aug 25, 2022
CYP4F2-Catalyzed Metabolism of Arachidonic Acid Promotes Stromal Cell-Mediated Immunosuppression in Non-Small Cell Lung Cancer.

Xuehan Chen, Yanzhuo Liu, Yang Wang

|Feb 21, 2022
Different clinical significance of novel B7 family checkpoints VISTA and HHLA2 in human lung adenocarcinoma.

Long Long, Li Zhang, Yuhan Yang

Pageof 2

Frequent Collaborators

1 joint publications

Jun Sun

1 joint publications

Abdalla Adam

1 joint publications

Suyu Liu

1 joint publications

Michael J Overman